Yang Yu

Phase I trial of "bi-shRNAi(furin)/GMCSF DNA/autologous tumor cell" vaccine (FANG) in advanced cancer.

D. Rao, N. Senzer, J. Nemunaitis, 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

Phase I Trial of TGF-β2 Antisense GM-CSF Gene-Modified Autologous Tumor Cell (TAG) Vaccine

N. Senzer, J. Nemunaitis, A. Tong, 2011, Clinical Cancer Research.

FANG Vaccine : Autologous Tumor Cell Vaccine Genetically Modified to Express GM-CSF and Block Production of Furin

D. Rao, N. Senzer, J. Nemunaitis, 2010 .

Safety and in vivo Expression of a GNE-Transgene: A Novel Treatment Approach for Hereditary Inclusion Body Myopathy-2

N. Senzer, J. Nemunaitis, N. Templeton, 2009, Gene regulation and systems biology.

Resveratrol Exerts Antioxidant Effects by Activating SIRT2 To Deacetylate Prx1.

Jiangyun Wang, Yang Yu, Jing Yuan, 2017, Biochemistry.

Phase I Trial of "bi-shRNAifurin/GMCSF DNA/Autologous Tumor Cell" Vaccine (FANG) in Advanced Cancer.

D. Rao, N. Senzer, J. Nemunaitis, 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

The use of a tumor metastasis targeting peptide to deliver doxorubicin-containing liposomes to highly metastatic cancer.

Qiang Zhang, Jiancheng Wang, J. Cui, 2012, Biomaterials.

LyP-1 modification to enhance delivery of artemisinin or fluorescent probe loaded polymeric micelles to highly metastatic tumor and its lymphatics.

Qiang Zhang, Jiancheng Wang, Hua Zhang, 2012, Molecular pharmaceutics.

A specific peptide ligand-modified lipid nanoparticle carrier for the inhibition of tumor metastasis growth.

Qiang Zhang, Jiancheng Wang, J. Cui, 2013, Biomaterials.